Wendy Bindeman

830 total citations
10 papers, 264 citations indexed

About

Wendy Bindeman is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Wendy Bindeman has authored 10 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Wendy Bindeman's work include Cancer Immunotherapy and Biomarkers (3 papers), RNA modifications and cancer (2 papers) and Cancer Research and Treatments (2 papers). Wendy Bindeman is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), RNA modifications and cancer (2 papers) and Cancer Research and Treatments (2 papers). Wendy Bindeman collaborates with scholars based in United States, Germany and United Kingdom. Wendy Bindeman's co-authors include Delong Liu, Shuhang Wang, Barbara Fingleton, Daniel S. Peiffer, I. Caroline Le Poole, Shilpak Chatterjee, Hee-Kap Kang, Jonathan M. Eby, Shikhar Mehrotra and Alex A. Adjei and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Wendy Bindeman

8 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy Bindeman United States 5 142 137 69 47 36 10 264
Hongyan Huang China 6 120 0.8× 130 0.9× 122 1.8× 18 0.4× 25 0.7× 8 271
Jenny Landsberg Germany 7 81 0.6× 124 0.9× 102 1.5× 14 0.3× 37 1.0× 7 227
Robert J. Van Gulick United States 9 68 0.5× 122 0.9× 129 1.9× 16 0.3× 24 0.7× 14 242
Kelsey W. Nassar United States 5 84 0.6× 170 1.2× 164 2.4× 14 0.3× 36 1.0× 6 284
Linda Tran United States 5 101 0.7× 149 1.1× 169 2.4× 22 0.5× 36 1.0× 6 334
Jennifer Dine United States 7 71 0.5× 162 1.2× 114 1.7× 10 0.2× 41 1.1× 14 309
Pierre‐Emmanuel Stoebner France 10 48 0.3× 108 0.8× 126 1.8× 47 1.0× 24 0.7× 27 263
Zachary T. Kneass United States 4 131 0.9× 82 0.6× 265 3.8× 32 0.7× 26 0.7× 4 354
Xueliang Ding China 8 82 0.6× 90 0.7× 113 1.6× 48 1.0× 23 0.6× 10 241
Yosuke Kubo Japan 7 171 1.2× 222 1.6× 82 1.2× 6 0.1× 48 1.3× 11 333

Countries citing papers authored by Wendy Bindeman

Since Specialization
Citations

This map shows the geographic impact of Wendy Bindeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Bindeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Bindeman more than expected).

Fields of papers citing papers by Wendy Bindeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Bindeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Bindeman. The network helps show where Wendy Bindeman may publish in the future.

Co-authorship network of co-authors of Wendy Bindeman

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Bindeman. A scholar is included among the top collaborators of Wendy Bindeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Bindeman. Wendy Bindeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bindeman, Wendy, Kevin C. Corn, Marjan Rafat, & Barbara Fingleton. (2025). Loss of IL13RA2 promotes metastatic tumor growth in triple-negative breast cancer via increased AKT and NF-κB signaling. Clinical & Experimental Metastasis. 42(5). 40–40.
2.
Bindeman, Wendy, et al.. (2024). Type II Interleukin-4 Receptor Activation in Basal Breast Cancer Cells Promotes Tumor Progression via Metabolic and Epigenetic Modulation. International Journal of Molecular Sciences. 25(9). 4647–4647. 2 indexed citations
3.
Redwood, Abena B., Xiaomei Zhang, Sahil Seth, et al.. (2021). The cytosolic iron–sulfur cluster assembly (CIA) pathway is required for replication stress tolerance of cancer cells to Chk1 and ATR inhibitors. npj Breast Cancer. 7(1). 152–152. 9 indexed citations
4.
Bindeman, Wendy & Barbara Fingleton. (2021). Glycosylation as a regulator of site-specific metastasis. Cancer and Metastasis Reviews. 41(1). 107–129. 23 indexed citations
5.
Priego, Neibla, Lucía Zhu, Cátia Monteiro, et al.. (2019). Abstract 2746: Stat3 labels a subpopulation of reactive astrocytes required for brain metastasis. Tumor Biology. 2746–2746. 3 indexed citations
6.
Priego, Neibla, Lucía Zhu, Cátia Monteiro, et al.. (2019). Abstract 2746: Stat3 labels a subpopulation of reactive astrocytes required for brain metastasis. Cancer Research. 79(13_Supplement). 2746–2746. 2 indexed citations
7.
Yan, Yiyi, Siyu Cao, Xin Liu, et al.. (2018). CX3CR1 identifies PD-1 therapy–responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy. JCI Insight. 3(8). 96 indexed citations
8.
Mansfield, Aaron S., Sheng Cao, Wendy Bindeman, et al.. (2017). Compromised efficacy of PD-L1 blockade therapy in axenic (germ-free) mice with syngeneic tumors. Annals of Oncology. 28. v422–v423.
9.
Liu, Delong, Shuhang Wang, & Wendy Bindeman. (2017). Clinical applications of PD-L1 bioassays for cancer immunotherapy. Journal of Hematology & Oncology. 10(1). 110–110. 67 indexed citations
10.
Eby, Jonathan M., Hee-Kap Kang, Wendy Bindeman, et al.. (2015). CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo. Journal of Investigative Dermatology. 135(6). 1574–1580. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongyan Huang Breakdown of academic impact, for papers by Jenny Landsberg Breakdown of academic impact, for papers by Robert J. Van Gulick Breakdown of academic impact, for papers by Kelsey W. Nassar Breakdown of academic impact, for papers by Linda Tran Breakdown of academic impact, for papers by Jennifer Dine Breakdown of academic impact, for papers by Pierre‐Emmanuel Stoebner Breakdown of academic impact, for papers by Zachary T. Kneass Breakdown of academic impact, for papers by Xueliang Ding Breakdown of academic impact, for papers by Yosuke Kubo
Rankless by CCL
2026